Have a feature idea you'd love to see implemented?
Let us know!
GKOS GLAUKOS Corp
Price (delayed)
$129.25
Market cap
$7.1B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.2
Enterprise value
$7.19B
Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery,
Highlights
The debt has shrunk by 59% YoY and by 59% QoQ
GLAUKOS's equity has increased by 48% QoQ and by 36% YoY
GLAUKOS's net income has decreased by 25% YoY and by 13% QoQ
GLAUKOS's EPS has decreased by 21% YoY and by 11% from the previous quarter
Key stats
What are the main financial stats of GKOS
Market
Valuations
Earnings
Shares outstanding
54.95M
Market cap
$7.1B
Enterprise value
$7.19B
Price to earnings (P/E)
N/A
Price to book (P/B)
9.79
Price to sales (P/S)
19.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
21.03
Revenue
$341.73M
EBIT
-$144.17M
EBITDA
-$105.01M
Free cash flow
-$81.73M
Per share
Balance sheet
Liquidity
EPS
-$3.2
Free cash flow per share
-$1.61
Book value per share
$13.21
Revenue per share
$6.74
TBVPS
$11.39
Total assets
$919.68M
Total liabilities
$254.52M
Debt
$156.61M
Equity
$665.16M
Working capital
$313.7M
Debt to equity
0.24
Current ratio
5.48
Quick ratio
4.53
Net debt/EBITDA
-0.8
Margins
Efficiency
Dividend
EBITDA margin
-30.7%
Gross margin
76.5%
Net margin
-46.4%
Operating margin
-39.7%
Return on assets
-17%
Return on equity
-30.9%
Return on invested capital
-19%
Return on capital employed
-17%
Return on sales
-42.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GKOS stock price
How has the GLAUKOS stock price performed over time
Intraday
0.82%
1 week
0.79%
1 month
6.31%
1 year
87.78%
YTD
62.6%
QTD
-0.79%
Financial performance
How have GLAUKOS's revenue and profit performed over time
Revenue
$341.73M
Gross profit
$261.52M
Operating income
-$135.67M
Net income
-$158.61M
Gross margin
76.5%
Net margin
-46.4%
GLAUKOS's net income has decreased by 25% YoY and by 13% QoQ
GKOS's operating income is down by 16% YoY
The company's gross profit rose by 16% YoY and by 5% QoQ
The revenue has grown by 15% YoY and by 4.7% from the previous quarter
Growth
What is GLAUKOS's growth rate over time
Valuation
What is GLAUKOS stock price valuation
P/E
N/A
P/B
9.79
P/S
19.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
21.03
GLAUKOS's EPS has decreased by 21% YoY and by 11% from the previous quarter
The price to book (P/B) is 85% more than the 5-year quarterly average of 5.3 and 11% more than the last 4 quarters average of 8.8
GLAUKOS's equity has increased by 48% QoQ and by 36% YoY
The P/S is 81% higher than the 5-year quarterly average of 10.6 and 37% higher than the last 4 quarters average of 14.0
The revenue has grown by 15% YoY and by 4.7% from the previous quarter
Efficiency
How efficient is GLAUKOS business performance
The ROIC is down by 41% year-on-year and by 23% since the previous quarter
The return on assets has declined by 33% year-on-year and by 14% since the previous quarter
The ROE has contracted by 27% YoY and by 3% from the previous quarter
GLAUKOS's ROS has decreased by 13% YoY and by 9% from the previous quarter
Dividends
What is GKOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GKOS.
Financial health
How did GLAUKOS financials performed over time
The company's total liabilities fell by 47% QoQ and by 46% YoY
The quick ratio has contracted by 17% YoY
The debt is 76% lower than the equity
The debt to equity has plunged by 72% from the previous quarter and by 70% YoY
The debt has shrunk by 59% YoY and by 59% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.